Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic
نویسندگان
چکیده
منابع مشابه
Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic
Cancer is a major health problem in the world. Advances made in cancer therapy have improved the survival of patients in certain types of cancer. However, the overall five-year survival has not significantly improved in the majority of cancer types. Major challenges encountered in having effective cancer therapy are development of drug resistance by the tumor cells, nonspecific cytotoxicity, an...
متن کاملMutation Analysis of TP53 Tumor Suppressor Gene in Colorectal Cancer in Patients from Iran (Kerman Province)
Objective(s) P53 is an important tumor suppressor, which is mutated in later stages of many cancers and leads to resistance to chemotherapy. The aim of this study was to reveal mutations of TP53 in colorectal cancer in Kerman province. Materials and Methods A total of Forty-three colon cancer specimens as paraffin block or fresh tissues, which passed stage IIIA, were selected. Three exons 5,...
متن کاملFrom the test tube to the table
The first commercial exploitation of genetic technologies in the 1980s sparked a continuing debate over their acceptability, ethics and implications for society. Since this time, cloning, genetic screening and gene therapy have become topics of an intense discussion about how to use the potential of biotechnology in the best interests of the public, while criticism and outrage are mostly direct...
متن کاملA candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.
Frequent allelic loss and homozygous deletions within chromosome 3p in human lung cancers have suggested that the 3p21.3 (370-kb) region contains a critical tumor suppressor gene(s) (TSG). With the exact identity/characteristics of such a gene(s) still unconfirmed, a lack of inactivating structural mutations in the expressed genes contained within this region may indicate that the 3p TSG(s) do ...
متن کاملhereditary spastic paraplegia: from gene to clinic
objective hereditary spastic paraplegia (hsp) is a degenerative disease of genetic origin affecting the corticospinal tracts in the spinal cord. there are three forms of inheritance: autosomal dominant hsp, autosomal rececive hsp and x-linked hsp. this disease is characterized by progressive spasticity of leg muscles with varying degrees of stiffness and weakness of other muscle groups. in this...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Drug Delivery
سال: 2011
ISSN: 2090-3014,2090-3022
DOI: 10.1155/2011/465845